Non-Antibody Products — page 90 of 94
Non-Antibody Products
Page 90 of 94
| Name | Description | Size | Catalog # | Supplier | |
|---|---|---|---|---|---|
| Withanone | between human ACE2 and the SARS-CoV-2 spike pr… | 500 µg | 11804-500 |
 CAYMAN CHEMICAL COMPANY |
More Info |
| MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2 | FRET substrate for the severe acute respiratory syndrome coronavirus main… | 1 mg | orb1140569 |
 BIORBYT LTD. |
More Info |
| choactase shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-41919-V |
 SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| Myocardin shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-43954-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| PTPLB shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-152585-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| Bepridil | Bepridil is a small molecule which can act as a Calcium channel blocker /… | 5 mg, 25 mg, | abx283283 |
 ABBEXA LTD |
More Info |
| FAR1 shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-96316-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| Ran GAP1 shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-37160-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| CITED4 shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-60387-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| AT-527 | HCV viral replication inhibitor. AT-527 is highly effective in the contro… | 1 g, 250 mg, 100 mg, 5 mg, 10 mM * 1 mL in DMSO | orb691966 |
BIORBYT LTD. |
More Info |
| P23 shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-62741-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| Escitalopram | /kg); prevents acid sphingomyelinase activation and subsequent ceramide re… | 10 mg | 22405-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Escitalopram | /kg); prevents acid sphingomyelinase activation and subsequent ceramide re… | 25 mg | 22405-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Escitalopram | /kg); prevents acid sphingomyelinase activation and subsequent ceramide re… | 5 mg | 22405-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Escitalopram | /kg); prevents acid sphingomyelinase activation and subsequent ceramide re… | 50 mg | 22405-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Tubercidin | infection of Calu-3 cells by SARS-CoV-2 (EC50 = 0.05 &m… | 10 mg | 35834-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Tubercidin | infection of Calu-3 cells by SARS-CoV-2 (EC50 = 0.05 &m… | 25 mg | 35834-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Tubercidin | infection of Calu-3 cells by SARS-CoV-2 (EC50 = 0.05 &m… | 5 mg | 35834-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Tubercidin | infection of Calu-3 cells by SARS-CoV-2 (EC50 = 0.05 &m… | 50 mg | 35834-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| CA150 shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-37728-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| BCoR shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-72635-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| FAR1 shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-145070-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| PACRGL shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-140318-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| Baricitinib | monkeys infected with SARS-CoV-2 at 4 mg / animal | 100 mg | 16707-100 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Baricitinib | monkeys infected with SARS-CoV-2 at 4 mg / animal | 25 mg | 16707-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Baricitinib | monkeys infected with SARS-CoV-2 at 4 mg / animal | 250 mg | 16707-250 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Baricitinib | monkeys infected with SARS-CoV-2 at 4 mg / animal | 50 mg | 16707-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Rhoifolin | migration, and TGF-β1-induced EMT in MDA-MB-231 cells at 10 and 40 &… | 1 mg | 35583-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Rhoifolin | migration, and TGF-β1-induced EMT in MDA-MB-231 cells at 10 and 40 &… | 10 mg | 35583-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Rhoifolin | migration, and TGF-β1-induced EMT in MDA-MB-231 cells at 10 and 40 &… | 25 mg | 35583-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Rhoifolin | migration, and TGF-β1-induced EMT in MDA-MB-231 cells at 10 and 40 &… | 5 mg | 35583-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| COG8 shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-93542-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| PACRGL shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-89319-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| P23 shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-62742-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| CD8-alpha shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-29247-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| CD8-alpha shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-43677-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| Maprotiline (hydrochloride) | induced by pp-VSV-SARS-CoV-2 infection in Vero cells at… | 100 mg | 15892-100 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Maprotiline (hydrochloride) | induced by pp-VSV-SARS-CoV-2 infection in Vero cells at… | 50 mg | 15892-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Maprotiline (hydrochloride) | induced by pp-VSV-SARS-CoV-2 infection in Vero cells at… | 500 mg | 15892-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| ELOVL6 shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-62271-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| Z-L-Phe-CMK | An inhibitor of SARS-CoV Mpro (Ki = 306 nM); selective for SARS-<… | 1 g | 15225-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Z-L-Phe-CMK | An inhibitor of SARS-CoV Mpro (Ki = 306 nM); selective for SARS-<… | 250 mg | 15225-250 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Z-L-Phe-CMK | An inhibitor of SARS-CoV Mpro (Ki = 306 nM); selective for SARS-<… | 500 mg | 15225-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Aplidine | possesses antiviral activity and is against SARS-CoV-2… | 10 mg, 100 mg, 250 mg, 1 g | orb1089613 |
BIORBYT LTD. |
More Info |
| Ethacridine (lactate) | at 10 µM; preincubation of viral particles reduces SARS-CoV
| 1 g |
40282-1 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| Ethacridine (lactate) | at 10 µM; preincubation of viral particles reduces SARS-CoV
| 10 g |
40282-10 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| Ethacridine (lactate) | at 10 µM; preincubation of viral particles reduces SARS-CoV
| 25 g |
40282-25 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| Ethacridine (lactate) | at 10 µM; preincubation of viral particles reduces SARS-CoV
| 5 g |
40282-5 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| Recombinant S2 Protein(Mammalian, C-Fc) | Recombinant 2019-nCoV S2 Protein is produced by our Mamm… | 50ug, 500ug, 1mg | DRA48-50ug |
 BON OPUS BIOSCIENCES LLC |
More Info |
| Mycophenolic acid | inhibitor: Inhibits IMPDH2, which interacts with SARS-CoV
| 100 mg, 500 mg, |
abx282489 |
|
ABBEXA LTD
More Info
|
|